BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12405439)

  • 1. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
    Leschek E; Pearlman SA; Boudreaux I; Meek R
    Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-E as a cause of hemolytic disease of the newborn.
    Cheepsattayakorn R; Fongsatitkul L; Chotinaruemol S; Mahawongtong M
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S1-4. PubMed ID: 9347637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
    Manoura A; Korakaki E; Hatzidaki E; Saitakis E; Maraka S; Papamastoraki I; Matalliotakis E; Foundouli K; Giannakopoulou C
    Pediatr Hematol Oncol; 2007; 24(1):69-73. PubMed ID: 17130116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
    Singhal PK; Singh M; Paul VK; Deorari AK; Ghorpade MG
    Indian Pediatr; 1992 Mar; 29(3):319-25. PubMed ID: 1612673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic anemia caused by non-D minor blood incompatibilities in a newborn.
    Tugcu AU; Ince DA; Turan O; Belen B; Olcay L; Ecevit A
    Pan Afr Med J; 2019; 33():262. PubMed ID: 31692740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization.
    Bilgin H; Eren A; Kara S
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):539-40. PubMed ID: 27353998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T; Minon JM; Rigo J
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fetomaternal anti-RH3, -4 (anti-E and anti-c) rhesus isoimmunization: a case report].
    Farnault L; Garcia-Meric P; Cortey A; Arnaud F
    Arch Pediatr; 2011 Feb; 18(2):176-82. PubMed ID: 21194903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of severe hemolytic disease of the newborn due to anti-Dia antibody].
    Lee SM; Im SJ; Park SE; Lee EY; Kim HH
    Korean J Lab Med; 2007 Oct; 27(5):373-6. PubMed ID: 18094604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.